Results 71 to 80 of about 204,163 (273)

Testicular Abscess an Unusual Cause for Febrile Neutropenia

The Scientific World Journal, 2008
Patients with good-risk disseminated testicular cancer are effectively managed with platinum-based chemotherapy. Febrile neutropenia is a dose-limiting event for many chemotherapy regimens.
Tal Grenader
doaj   +1 more source

High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer [PDF]

, 2005
Background: Docetaxel is one of the most effective antitumor agents currently available for the treatment of metastatic breast cancer (MBC). This phase II multicenter study prospectively analyzed the efficacy and toxicity of docetaxel given on a weekly ...
Ajani JA, Ando M, B. Dorn, C. Jackisch, C. Kentenich, Chan S, Chevallier B, Dieras V, G. Deutsch, Hainsworth JD, Hudis CA, J. Papke, J. Stamp, J. Stemmler, Kaplan EL, M. Malekmohammadi, M. Stauch, Nabholtz JM, O. Brudler, S. Leinung, Salminen E, Trudeau ME, U. Vehling-Kaiser, V. Heinemann, Valero V, W. Abenhardt, W. Mair   +26 more
core   +1 more source

Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa‐Based Regimen in Newly Diagnosed Primary CNS Lymphoma

International Journal of Cancer, EarlyView.
Primary central nervous system diffuse large B‐cell lymphoma (PCNS‐DLBCL) lacks an optimal first‐line induction strategy, particularly for older patients and those ineligible for intensive consolidation. In this retrospective cohort of 36 newly diagnosed patients, the rituximab + methotrexate + thiotepa (RMT) regimen as first‐line induction achieved ...
Haotian Wang, Jia Li, Luming Cao, Ying Zhang, Xin Wan, Xingtong Wang, Yangzhi Zhao, Zhaoxia Li, Chengqian Chen, Yang Song, Ou Bai   +10 more
wiley   +1 more source

Triagem para o tratamento ambulatorial da neutropenia febril Screening for the outpatient treatment of febrile neutropenia

Revista Brasileira de Hematologia e Hemoterapia, 2010
A neutropenia febril (NF) é uma complicação frequente e potencialmente fatal nos pacientes em tratamento quimioterápico. Entendemos hoje que a neutropenia febril é considerada uma emergência clínica e que a administração de antibióticos de amplo espectro
Marcelo Bellesso, Silvia Figueiredo Costa, Dalton Alencar Fischer Chamone, Pedro Enrique Dorlhiac Llacer   +3 more
doaj   +1 more source

Composite Adverse Event Outcome in Pediatric Cancer Patients with Prolonged Febrile Neutropenia [PDF]

Journal of Microbiology and Infectious Diseases, 2016
Objective: Pediatric cancer patients with prolonged febrile neutropenia have increased risk for severe, recurrent or new bacterial and fungal infection.
Muhammad Matloob Alam
doaj   +1 more source

Clinical trial of safety and antitumor activity of farletuzumab ecteribulin in patients with platinum‐resistant ovarian cancer: Phase I expansion results

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective In the dose‐escalation part of Study 101, which included multiple tumor types, objective responses were observed in 10 of 22 patients across multiple dose levels of farletuzumab ecteribulin (FZEC). We explored the safety/antitumor activity of FZEC in patients with platinum‐resistant ovarian cancer (PROC) from the Study 101 expansion ...
Kan Yonemori, Mayu Yunokawa, Koji Matsumoto, Kazuhiro Takehara, Kosei Hasegawa, Yasuyuki Hirashima, Hidenori Kato, Hiroki Ikezawa, Yohei Otake, Wataru Yusa, Takuma Miura, Shin Nishio   +11 more
wiley   +1 more source

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update

Advances in Hematology, 2014
Febrile neutropenia is one of the most serious complications in patients with haematological malignancies and chemotherapy. A prompt identification of infection and empirical antibiotic therapy can prolong survival.
Paola Villafuerte-Gutierrez, Lucia Villalon, Juan E. Losa, Cesar Henriquez-Camacho   +3 more
doaj   +1 more source

Primary prophylaxis of neutropenia in women affected by breast cancer undergoing adjuvant chemotherapy with fec 100+/- docetaxel. Comparison of efficacy and tolerability between lenograstim and pegfilgrastim [PDF]

, 2015
Objectives: evaluate safety and toxicity of a single injection of pegfilgrastim compared to daily administration of lenograstim in breast cancer patient undergoing adjuvant ...
Caruso, Davide, Congedi, Fp, Giannarelli, D, Giordani, Erika, Papa, Anselmo, Ricci, Fabio, Rossi, Luigi Enrico, Tomao, Federica, Verrico, Monica, Zaccarelli, Eleonora   +9 more
core   +1 more source

Differentiation Syndrome and Sweet Syndrome‐Like Overlap Following Venetoclax–Azacytidine and G‐CSF Therapy

JEADV Clinical Practice, EarlyView.
ABSTRACT Differentiation syndrome (DS) and Sweet syndrome (SS) are inflammatory complications mediated by cytokine dysregulation, classically associated with therapies that promote myeloid differentiation or cytokine release. While DS has been primarily linked to all‐trans retinoic acid (ATRA) and IDH inhibitors, recent evidence suggests that ...
Katerina Grafanaki, Maria Gerbesi, Zoe Apalla, Dimitrios Tsokanas, Efstathia Pasmatzi, Alexandros Spyridonidis, Maria Liga   +6 more
wiley   +1 more source

Uso de factores de crescimento de granulócitos: recomendações da Sociedade Portuguesa de Hematologia.

Acta Médica Portuguesa, 2008
The administration of cytotoxic chemotherapy may be complicated by the emergence of neutropenia and febrile neutropenia, frequently determining hospital admission and intravenous treatment with broad spectrum antibiotics.
João Forjaz de Lacerda, Fernando Leal da Costa, Ana Marques Pereira, Fernando Príncipe, Adriana Teixeira, António Parreira   +5 more
doaj   +1 more source